Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Antiviral Research|June 3, 2008
A case for developing antiviral drugs against polioMarc S Collett, Johan Neyts, John F ModlinAntiviral Research|October 4, 2005
Insights into the genetic basis for natural phenotypic resistance of human rhinoviruses to pleconarilRebecca M Ledford, Marc S Collett, Daniel C PevearClinical and Vaccine Immunology : CVI|July 1, 2011
Immunogenicity of inactivated polio vaccine with concurrent antiviral V-073 administration in miceDiana Kouiavskaia, Marc S Collett, Eugenia M Dragunsky, et al.Antimicrobial Agents and Chemotherapy|August 9, 2021
A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of V-7404 in Healthy Adult VolunteersMartin K Kankam, Jennifer M Burns, Marc S Collett, et al.Antimicrobial Agents and Chemotherapy|July 29, 2009
In vitro antiviral activity of V-073 against poliovirusesM Steven Oberste, Deborah Moore, Barbara Anderson, et al.Elife|November 4, 2014
Dominant drug targets suppress the emergence of antiviral resistanceElizabeth J Tanner, Hong-mei Liu, M Steven Oberste, et al.Journal of Virology|August 28, 2004
Newly synthesized hepatitis C virus replicon RNA is protected from nuclease activity by a protease-sensitive factor(s)Guang Yang, Daniel C Pevear, Marc S Collett, et al.Antimicrobial Agents and Chemotherapy|October 28, 2005
Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinovirusesDaniel C Pevear, Frederick G Hayden, Tina M Demenczuk, et al.Antiviral Therapy|October 26, 2011
Immunological and pathogenic properties of poliovirus variants selected for resistance to antiviral drug V-073Diana V Kouiavskaia, Eugenia M Dragunsky, Hong-Mei Liu, et al.Journal of Virology|March 16, 2004
VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compoundsRebecca M Ledford, Nitesh R Patel, Tina M Demenczuk, et al.Pageof 2